Aripiprazole in Children and Adolescents With Bipolar I Disorder

Completed · Phase 3 · Has a placebo group

Conditions studied: Bipolar Disorder

In brief

The purpose of this trial is to test the safety and efficacy of two doses of aripiprazole in child and adolescent patients with bipolar I disorder, manic or mixed episode with or without psychotic features.

Key facts

Study ID
NCT00110461
Run by
Otsuka Pharmaceutical Development & Commercialization, Inc.
People needed
296
Starts
2005-03-01
Expected to finish
2007-02-01
Last updated by the study team
2012-05-21

Who can join

Age: 10 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.